All three products are built on our proprietary TFT-DNA technology — a groundbreaking solution that merges thin-film transistor (TFT) chip technology with electrochemical DNA synthesis, which is engineered to deliver DNA products at lower costs, higher throughput, and faster turnaround times. This next-generation synthesis platform is set to empower fields such as high-throughput biotechnology, synthetic biology, biomolecular drug discovery, and molecular diagnostics.

As the world’s first benchtop oligonucleotide microarray synthesizer powered by TFT semiconductor technology, our TruSynth™ system has successfully demonstrated our end-to-end platform capabilities — from the chip to the synthesizer, and final synthesis product. We have completed the development of six generations of TruSynth™ alpha testers and initiated the beta test with our early-stage customers. Our high-quality oligonucleotide microarrays and oligo pools are now available for delivery.

LinkZill is actively collaborating with early adopters to uncover groundbreaking application scenarios of TFT semiconductors in life sciences. We invite you to connect with us and unlock what’s next — together.